Ceftizoxime
- Level
- Commodity
- Parent
- 51284100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51284120This classification denotes an anti-bacterial agent with the molecular formula C13H13N5O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C43C467DPE, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6r-(6alpha,7beta(z)))- but generally known as ceftizoxime, which bears US NIH Compound Identifier 6533629. European Medicines Agency schedules Ceftizoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07429MIG. The term CEFTIZOXIME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules ceftizoxime in its Anatomical Therapeutic Chemical (ATC) Classification. CEFTIZOXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ceftizoxime under HS 29419000 and SITC 54139. As of Q4 2014, CEFTIZOXIME remains the US FDA Preferred Term for this commodity. Ceftizoxime bears US NLM identifiers UMLS ID C0007560 and NCI Concept Code C61668. SMILES: S1C2N(C(=O)C2NC(=O)/C(=N\OC)C2NC(SC2)N)C(=CC1)C(=O)O.
Same parent
Under 51284100 · 50Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.